Skip to main content
SpringerLink
Log in

Weitere Problemfelder der Gerontopharmakotherapie und pragmatische Empfehlungen

  • Chapter
Arzneitherapie für Ältere

Zusammenfassung

Adherence, zuvor häufig als Compliance beschrieben, ist definiert als Übereinstimmung zwischen dem Verhalten des Patienten und dem aufgestellten Therapieplan (Haynes 1979). Dies betrifft selbstverständlich nicht nur Pharmakotherapie, sondern auch andere gesundheitsrelevante Ratschläge, die von Funktionsträgern des Gesundheitssystems gegeben werden. Trotz der großen Bedeutung des Adherenceproblems gibt es relativ wenig schlüssige Daten und insgesamt zu wenig Anstrengungen, diesen wichtigen Aspekt der Pharmakotherapie weiter zu erhellen. Dies beruht nicht zuletzt auf methodologischen Problemen, z. B. korrekte Prävalenzdaten einer Non-Adherence zu erheben, was sogar in kontrollierten klinischen Untersuchungen auf erhebliche Schwierigkeiten stößt (Kruse 1995; Spilker 1991).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Balkrishnan R (1998) Predictors of medication adherence in the elderly. Clin Ther 20(4):764–771

    Article  PubMed  CAS  Google Scholar 

  • Beier ME, Ackerman PL (2003) Determinants of health knowledge: an investigation of age, gender, abilities, personality, and interests. J Pers Soc Psychol :439–448

    Google Scholar 

  • Burkhardt H, Karaminejad E, Gladisch R (2006) A short performance test can help to predict adherence to self-administration of insulin in elderly patients with diabetes. Age Ageing 35(4):449–450

    Article  PubMed  CAS  Google Scholar 

  • Charles C, Gafni A, Whelan T (1999) Decision-making in the physician- patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49:651–661

    Article  PubMed  CAS  Google Scholar 

  • Deinzer A, Babel H, Veelken R, Kohnen R, Schmieder RE (2006) Shared decision-making mit Bluthochdruckpatienten. Ergebnisse einer Implementierung in Deutschland. Dtsch Med Wochenschr 131:2592–2596

    Article  PubMed  CAS  Google Scholar 

  • Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC (1991) Medication adherence patterns in chronic obstructive pulmonary disease. Chest 99(4):837–841

    Article  PubMed  CAS  Google Scholar 

  • Fincham E (1988) Patient compliance in the ambulatory elderly: a review of the literature. J Geriat Drug Ther 2:31–52

    Article  Google Scholar 

  • Fischbeck S (2003) Zum Bedürfnis onkologischer Patienten nach therapiebezogener Mitbestimmung. Befunde empirischer Forschung. In: F Scheibler, H Pfaff (Ed) Shared decision- making. Der Patient als Partner im medizinischen Entscheidungsprozess. Juventa, Weinheim, pp 46–55

    Google Scholar 

  • Freidson E (1970) Professional dominance: the social structure of medical care. Atherton, New York

    Google Scholar 

  • Haynes, RB (1979) Introduction. In: RB Haynes, DW Taylor, DL Sackett (eds) Compliance in health care. The Johns Hopkins University Press, Baltimore

    Google Scholar 

  • Higgins N, Regan C (2004) A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 33:224–229

    Article  PubMed  Google Scholar 

  • Hughes CM (2004) Medication non-adherence in the elderly: how big is the problem? Drugs Aging 21:793–811

    Article  PubMed  Google Scholar 

  • Kruse WHH. Comprehensive geriatric assessment and medication compliance. Z Gerontol Geriat 1995, 28:54–61

    CAS  Google Scholar 

  • Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens Suppl. 1998 Jan;16(1):S75–79

    PubMed  CAS  Google Scholar 

  • McElnay Jc, McCallion CR. Adherence and the elderly. In: LB Myers, K Midence (eds) Adherence to treatment in medical conditions. Harwood Academic Publishers 1998, Amsterdam

    Google Scholar 

  • Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G. Elderly patients´problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol 1996, 49:255–259

    Article  PubMed  CAS  Google Scholar 

  • Owens NJ, Larrat EP, Fretwell MD. Improving compliance in the older patient. In: JA Cramer, B Spilker (eds) Patient compliance in medical practice and clinical trials. Raven Press, New York, pp 107–119

    Google Scholar 

  • Petermann F, Mühlig S (1998) Grundlagen und Möglichkeiten der Compliance-Verbesserung. In: F Petermann (Hrsg) Compliance und Selbstmanagement. Hogrefe, Göttingen, S 73–102

    Google Scholar 

  • Ried LD, Christensen DN (1988) A psychosocial perspective in the explanation of patients´ drug-taking behavior. Soc Sci Med 27:277–285

    Article  PubMed  CAS  Google Scholar 

  • Rivers PH (1992) Compliance aids – do they work? Drugs Aging 2:103–111

    Article  PubMed  CAS  Google Scholar 

  • Rosenstock IM (1975) Patients´ compliance with health regimens. JAMA 234:402–403

    Article  PubMed  CAS  Google Scholar 

  • Spagnoli A, Ostino G, Borga AD et al. (1989) Drug compliance and unreported drugs in the elderly. J Am Geriatr Soc 37:619–624

    PubMed  CAS  Google Scholar 

  • Spilker B (1991) Methods of assessing and improving patient compliance in clinical trials. In: JA Cramer, B Spilker (eds) Patient compliance in medical practice and clinical trials. Raven, New York, pp 37–56

    Google Scholar 

  • Widiger TA, Seidlitz L (2002) Personality, psychopathology, and aging. J Res Pers 36:335–362

    Article  Google Scholar 

Literatur

  • Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. The Oncologist 5:224–237

    Article  PubMed  CAS  Google Scholar 

  • Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157(14):1531–1536

    Article  PubMed  CAS  Google Scholar 

  • Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294(6):716–724

    Article  PubMed  CAS  Google Scholar 

  • Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN (2008) Polypharmacy: misleading, but manageable. Clin Interv Aging 3(2):383–389

    PubMed  Google Scholar 

  • Chutka DS, Takahashi PY, Hoel RW (2004) Inappropriate medications for elderly patients. Mayo Clin Proc 79(1):122–139

    Article  PubMed  CAS  Google Scholar 

  • Fick DM, Waller JL, Maclean JR et al. (2001) Potentially inappropriate medication use in a managed care population: association with higher costs and utilization. J Manag Care Pharm 7:407–413

    Google Scholar 

  • Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724

    Article  PubMed  Google Scholar 

  • Flockhart DA (2009) Drug interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine. http://www.medicine.iupui.edu/clinpharm/ddis/table.asp. Gesehen 20.09.2009

  • Garfinkel D, Zur-Gil S, Ben-Israel J (2007) The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 9(6):430–434

    PubMed  Google Scholar 

  • Glaeske G, Hoffmann F (2009) Der Wettbewerb der Leitlinien bei älteren Menschen – Multimorbidität und Polypharmazie als Problem. Neuro Geriatrie 6:115–119

    Google Scholar 

  • Gurwitz JH (2004) Polypharmacy. A new paradigm for quality drug therapy in the elderly? Arch Intern Med 164:1957–1959

    Article  PubMed  Google Scholar 

  • Hanlon JT, Fillenbaum GG, Kuchibhatla M et al. (2002) Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 40(2):166–176

    Article  PubMed  Google Scholar 

  • Holt S, Schmiedl S, Thürmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Ärztebl Int 107:543–551

    PubMed  Google Scholar 

  • National Center for Health Statistics (1996) National Health and Nutrition Examination Survey (NHANES) III. http://www.cdc.gov/nchs/nhanes/nh3data.htm. Gesehen 11.1.2010

  • Palareti G, Legnani C (1996) Warfarin withdrawal – Pharmacokinetic– pharmacodynamic considerations. Clin Pharmacokinet 30:300–313

    Article  PubMed  CAS  Google Scholar 

  • Pientka L, Friedrich C (2002) Grundlagen Geriatrie. Geriatrisches Assessment und dessen Nutzen für die Onkologie. Onkologe 8:140–150

    Article  Google Scholar 

  • Podrazik PM, Schwartz JB (1999) Cardiovascular pharmacology of aging. Cardiol Clin 17:17–34

    Article  PubMed  CAS  Google Scholar 

  • Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315:1096–1099

    PubMed  CAS  Google Scholar 

  • Rollason V, Vogt N (2003) Reduction of polypharmacy in the elderly. Drugs Aging 20:817–832

    Article  PubMed  Google Scholar 

  • Semla TP, Beizer JL, Higbee MD (2003) Geriatric dosage handbook. 9th edn, Lexi Comp, Hudson

    Google Scholar 

  • Steinhagen-Thiessen E, Borchelt M (2001) Morbidity, medication, and functional limitations in very old age. In: The Berlin Aging Study, aging from 70 to 100. Cambridge University Press, Cambridge

    Google Scholar 

  • Stuck A, Kharicha K, Dapp U et al. (2007) Development, feasibility and performance of a health risk appraisal questionnaire for older persons. BMC Medical Research Methodology 7:1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinischen Klinik (Schwerpunkt Geriatrie), Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim

    Priv.-Doz. Dr. med. Heinrich Burkhardt

Authors
  1. Priv.-Doz. Dr. med. Heinrich Burkhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Burkhardt, H. (2011). Weitere Problemfelder der Gerontopharmakotherapie und pragmatische Empfehlungen. In: Arzneitherapie für Ältere. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17308-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-17308-0_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-17307-3

  • Online ISBN: 978-3-642-17308-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation